Abstract
Interstitial lung diseases comprise a large group of pulmonary disorders characterized by lung inflammation and fibrosis. Often, these disorders are progressive leading to irreversible tissue scaring. The absence of effective and safe anti-fibrotic drugs has prompted the search for targets for intervention that could lead to new strategies for treatment. Animal models of lung fibrosis, although not resembling exactly the human condition, represent invaluable tools for the exploration of the factors and mechanisms involved in the development of lung fibrosis. In this review, we briefly discuss current concepts related to the pathogenesis of lung fibrosis followed by a more thorough discussion of currently available animal models of lung fibrosis. Experimental models induced by chemical agents, haptens, infection, genetic manipulation, and irradiation are discussed as are cell-mediated models and spontaneous models of lung fibrosis in domestic animals.
Keywords: Animal model, epithelial-mesenchymal transition, idiopathic pulmonary fibrosis, inflammation, interstitial lung disease, myofibroblast, epithelial cell.
Current Respiratory Medicine Reviews
Title:Animal Models of Lung Fibrosis
Volume: 11 Issue: 2
Author(s): Gianluca Bagnato and Jesse Roman
Affiliation:
Keywords: Animal model, epithelial-mesenchymal transition, idiopathic pulmonary fibrosis, inflammation, interstitial lung disease, myofibroblast, epithelial cell.
Abstract: Interstitial lung diseases comprise a large group of pulmonary disorders characterized by lung inflammation and fibrosis. Often, these disorders are progressive leading to irreversible tissue scaring. The absence of effective and safe anti-fibrotic drugs has prompted the search for targets for intervention that could lead to new strategies for treatment. Animal models of lung fibrosis, although not resembling exactly the human condition, represent invaluable tools for the exploration of the factors and mechanisms involved in the development of lung fibrosis. In this review, we briefly discuss current concepts related to the pathogenesis of lung fibrosis followed by a more thorough discussion of currently available animal models of lung fibrosis. Experimental models induced by chemical agents, haptens, infection, genetic manipulation, and irradiation are discussed as are cell-mediated models and spontaneous models of lung fibrosis in domestic animals.
Export Options
About this article
Cite this article as:
Bagnato Gianluca and Roman Jesse, Animal Models of Lung Fibrosis, Current Respiratory Medicine Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573398X11666150619183100
DOI https://dx.doi.org/10.2174/1573398X11666150619183100 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Topical Delivery of Antioxidants
Current Drug Delivery Imaging Features of Thoracic Manifestations of Behçet’s Disease: Beyond Pulmonary Artery Involvement
Current Medical Imaging Treatment of Hypertension in Chronic Kidney Disease: Does one Size Fit All? A Narrative Review from a Nephrologist’s Perspective
Current Hypertension Reviews The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini-Reviews in Medicinal Chemistry Perioperative Considerations in Rheumatoid Arthritis Patients
Current Rheumatology Reviews An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions
Current Pharmaceutical Design Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry Pathologic Findings of Autoimmune Pancreatitis and IgG4-Related Disease
Current Immunology Reviews (Discontinued) Editorial (Thematic Issue: Cell Immunity in Cardiovascular and Cerebrovascular Diseases)
Current Immunology Reviews (Discontinued) Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Anticancer Potential of Doxorubicin in Combination with Green-Synthesized Silver Nanoparticle and its Cytotoxicity Effects on Cardio-Myoblast Normal Cells
Anti-Cancer Agents in Medicinal Chemistry Neuroprotection by Diazoxide in Animal Models for Cerebrovascular Disorders
Vascular Disease Prevention (Discontinued) Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Gold Salts Therapy in Respiratory Diseases
Current Respiratory Medicine Reviews Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine